Eric J G Sijbrands

Author PubWeight™ 214.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010 28.21
2 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 17.89
3 Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008 14.01
4 Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 13.25
5 Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2008 12.32
6 Genome-wide association study of blood pressure and hypertension. Nat Genet 2009 11.54
7 High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2007 4.69
8 A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012 4.37
9 Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011 3.68
10 Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004 3.55
11 Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 2008 3.54
12 Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 2011 3.40
13 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
14 Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008 2.62
15 Evaluation of risk prediction updates from commercial genome-wide scans. Genet Med 2009 2.30
16 Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care 2010 2.14
17 Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve. Am J Epidemiol 2010 2.06
18 Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care 2009 2.03
19 Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007 1.86
20 Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 2004 1.84
21 Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur Heart J 2008 1.80
22 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
23 The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med 2013 1.70
24 SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 2009 1.44
25 Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing. Eur Heart J Cardiovasc Imaging 2012 1.44
26 Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations. Circ Cardiovasc Genet 2011 1.44
27 Increased aortic stiffness and blood pressure in non-classic Pompe disease. J Inherit Metab Dis 2014 1.44
28 The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 2010 1.41
29 Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis. Atherosclerosis 2013 1.41
30 Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography. J Nucl Cardiol 2012 1.41
31 Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 2007 1.34
32 Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy. J Am Coll Cardiol 2010 1.20
33 Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study. Eur J Epidemiol 2007 1.20
34 A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 2010 1.17
35 A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Curr Diab Rep 2011 1.16
36 Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS One 2010 1.14
37 Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes 2011 1.13
38 Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet 2011 1.11
39 Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 2009 1.11
40 Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 2002 1.11
41 Value of genetic profiling for the prediction of coronary heart disease. Am Heart J 2009 1.10
42 Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 2009 1.06
43 Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes 2009 1.05
44 Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002 1.03
45 Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies. Eur J Hum Genet 2008 1.02
46 Cascade Screening for Familial Hypercholesterolemia (FH). PLoS Curr 2011 0.98
47 High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants. Atherosclerosis 2007 0.98
48 SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin. Free Radic Biol Med 2009 0.97
49 Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia. Am J Cardiol 2008 0.97
50 Variants in the SIRT1 gene may affect diabetes risk in interaction with prenatal exposure to famine. Diabetes Care 2012 0.95
51 Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study. BMC Med 2008 0.95
52 Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis. Hum Genet 2003 0.93
53 Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol 2010 0.93
54 Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis. Circ Heart Fail 2012 0.92
55 Far-wall pseudoenhancement during contrast-enhanced ultrasound of the carotid arteries: clinical description and in vitro reproduction. Ultrasound Med Biol 2012 0.91
56 Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children. Circulation 2003 0.89
57 Glycemic index and glycemic load and their association with C-reactive protein and incident type 2 diabetes. J Nutr Metab 2011 0.88
58 Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. J Vasc Surg 2012 0.87
59 Usefulness of contrast-enhanced ultrasound for detection of carotid plaque ulceration in patients with symptomatic carotid atherosclerosis. Am J Cardiol 2013 0.86
60 15-Year outcome after normal exercise ⁹⁹mTc-sestamibi myocardial perfusion imaging: what is the duration of low risk after a normal scan? J Nucl Cardiol 2012 0.85
61 Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance. Eur J Hum Genet 2007 0.85
62 Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large. Exp Gerontol 2007 0.85
63 Meat consumption and its association with C-reactive protein and incident type 2 diabetes: the Rotterdam Study. Diabetes Care 2012 0.84
64 Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia. J Clin Endocrinol Metab 2008 0.84
65 Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index. Am J Clin Nutr 2010 0.84
66 ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia. Atherosclerosis 2008 0.84
67 Assessment of subclinical atherosclerosis using contrast-enhanced ultrasound. Eur Heart J Cardiovasc Imaging 2012 0.84
68 Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels. J Clin Endocrinol Metab 2007 0.84
69 Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia. Atherosclerosis 2008 0.83
70 The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway. Eur Heart J 2009 0.83
71 Impact of an alerting clinical decision support system for glucose control on protocol compliance and glycemic control in the intensive cardiac care unit. Diabetes Technol Ther 2011 0.82
72 Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes. Eur J Hum Genet 2009 0.82
73 Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial. Circulation 2005 0.82
74 Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension. Am J Hypertens 2012 0.82
75 A functional polymorphism in the glucocorticoid receptor gene and its relation to cardiovascular disease risk in familial hypercholesterolemia. J Clin Endocrinol Metab 2006 0.82
76 Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-enhanced ultrasound in patients with familial hypercholesterolemia. Atherosclerosis 2013 0.82
77 Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging 2013 0.82
78 Effect of carotid plaque screening using contrast-enhanced ultrasound on cardiovascular risk stratification. Am J Cardiol 2012 0.81
79 Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia. Eur Heart J 2008 0.81
80 Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2013 0.81
81 Daily red wine consumption improves vascular function by a soluble guanylyl cyclase-dependent pathway. Am J Hypertens 2010 0.81
82 Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies. Circ Cardiovasc Imaging 2010 0.81
83 Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes. Acta Diabetol 2014 0.80
84 The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial. BMC Public Health 2012 0.80
85 Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural history. J Am Coll Cardiol 2011 0.80
86 A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients. Eur Heart J 2010 0.79
87 Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Am J Hypertens 2009 0.79
88 Arterial stiffness and hypertension in a large population of untreated individuals: the Rotterdam Study. J Hypertens 2014 0.79
89 Red wine extract protects against oxidative-stress-induced endothelial senescence. Clin Sci (Lond) 2012 0.79
90 Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Semin Vasc Med 2004 0.79
91 Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E? Diabetes 2006 0.79
92 Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur Heart J 2008 0.79
93 Low-density lipoprotein receptor mutations generate synthetic genome-wide associations. Eur J Hum Genet 2012 0.78
94 Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality. Atherosclerosis 2011 0.78
95 Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium. Am J Med Genet B Neuropsychiatr Genet 2010 0.78
96 Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet 2012 0.78
97 The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health 2012 0.77
98 The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia. Pediatr Res 2003 0.76
99 Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study. Atherosclerosis 2004 0.76
100 Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin. Hypertension 2006 0.76
101 Patients with chronic gastrointestinal ischemia have a higher cardiovascular disease risk and mortality. Atherosclerosis 2012 0.76
102 Nitrite- and nitroxyl-induced relaxation in porcine coronary (micro-) arteries: underlying mechanisms and role as endothelium-derived hyperpolarizing factor(s). Pharmacol Res 2012 0.76
103 Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summary. J Atheroscler Thromb 2014 0.76
104 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia. Atherosclerosis 2009 0.75
105 [Another indicator of correlation between cholesterol and type 2 diabetes mellitus]. Ned Tijdschr Geneeskd 2015 0.75
106 [Diabetologist 2.0; patients perform diabetic tests using a multilingual robot]. Ned Tijdschr Geneeskd 2014 0.75